In HF patients with atrial fibrillation, oral factor Xa inhibitors compared to VKA provided at least equally effective stroke prevention, but caused less serious bleeding complications similar to what has been observed in other high risk constellations such as combined antithrombotic therapies [44]. This evidence concerns the gene F10 and atrial fibrillation.